Glycomic and glycoproteomic analysis of serum from patients with stomach cancer reveals potential markers arising from host defense response mechanisms.
about
Glycomic Approaches for the Discovery of Targets in Gastrointestinal CancerNew blood markers detection technology: A leap in the diagnosis of gastric cancerEmerging blood-based biomarkers for detection of gastric cancerPerspectives on new biomarkers in gastric cancer: diagnostic and prognostic applicationsDevelopments in the identification of glycan biomarkers for the detection of cancerSerum glycoprotein-derived N- and O-linked glycans as cancer biomarkersMannose receptor (MR) engagement by mesothelin GPI anchor polarizes tumor-associated macrophages and is blocked by anti-MR human recombinant antibodyGlobal proteomics and metabolomics in cancer biomarker discovery.Increased sialylation of anti-Thomsen-Friedenreich antigen (CD176) antibodies in patients with gastric cancer: a diagnostic and prognostic potentialAlteration of the serum N-glycome of mice locally exposed to high doses of ionizing radiation.Comparative studies of the proteome, glycoproteome, and N-glycome of clear cell renal cell carcinoma plasma before and after curative nephrectomySerum glycan signatures of gastric cancer.N-glycomic profiling as a tool to separate rectal adenomas from carcinomas.Role of the unfolded protein response in regulating the mucin-dependent filamentous-growth mitogen-activated protein kinase pathway.Multidimensional liquid chromatography platform for profiling alterations of clusterin N-glycosylation in the plasma of patients with renal cell carcinoma.Functional Module Analysis for Gene Coexpression Networks with Network Integration.Smoking and lung cancer-induced changes in N-glycosylation of blood serum proteins.Chemoenzymatic method for glycomics: Isolation, identification, and quantitation.Biomarkers intersect with the exposomeAberrant glycosylation of the anti-Thomsen-Friedenreich glycotope immunoglobulin G in gastric cancer patients.Human plasma protein N-glycosylationGlycosylation of plasma IgG in colorectal cancer prognosis.Distribution of IgG galactosylation as a promising biomarker for cancer screening in multiple cancer types.The role of glycans in immune evasion: the human fetoembryonic defence system hypothesis revisitedBiomarkers of Helicobacter pylori-associated gastric cancer.Hidden IgG Antibodies to the Tumor-Associated Thomsen-Friedenreich Antigen in Gastric Cancer Patients: Lectin Reactivity, Avidity, and Clinical Relevance.Direct analysis of aberrant glycosylation on haptoglobin in patients with gastric cancer.Selectin Ligands Sialyl-Lewis a and Sialyl-Lewis x in Gastrointestinal Cancers.Recent advances in hydrophilic interaction liquid chromatography (HILIC) for structural glycomics.Acute phase glycoproteins: bystanders or participants in carcinogenesis?Divide and conquer: subproteomic approaches toward gastric cancer biomarker and drug target discovery.Clinical diagnostics and therapy monitoring in the congenital disorders of glycosylationInsights on N-glycosylation of human haptoglobin and its association with cancers.Protein-carbohydrate complex reveals circulating metastatic cells in a microfluidic assay.High-Throughput Analysis of the Plasma N-Glycome by UHPLC.Site-specific and linkage analyses of fucosylated N-glycans on haptoglobin in sera of patients with various types of cancer: possible implication for the differential diagnosis of cancer.Discovery of Non-invasive Glycan Biomarkers for Detection and Surveillance of Gastric CancerProtein-Specific Differential Glycosylation of Immunoglobulins in Serum of Ovarian Cancer Patients.Protein and site specificity of fucosylation in liver-secreted glycoproteins.The Use of Multiple Reaction Monitoring on QQQ-MS for the Analysis of Protein- and Site-Specific Glycosylation Patterns in Serum.
P2860
Q26750872-ABC06EBD-CED1-45F6-A8BA-B1A4957871C2Q26774503-452039A0-E6E5-455D-8684-BBBCE5A5FD3DQ26778026-27630BC5-B70E-48E3-866F-60DCBA66588DQ27012898-A471617B-05B0-497C-91B8-E08BFDF08DFDQ27026715-975E8832-67BF-47A6-8CF6-F41C29B66863Q28079101-61AFFFA5-8E70-4917-8AB3-C13434A6B141Q28478285-17AD1897-89A6-498E-AD45-032CF6A3FD71Q34079038-483076D4-ABC3-4944-B7C8-30A5923BF980Q34208137-50A2D7A9-9826-47CD-B223-324AC20D1F5AQ34475210-56CCEB0A-B625-4C37-AA71-403C8DF19695Q34488550-D5BFF706-D6B4-4F25-B620-1BE16180AE2CQ35064779-DC15189E-E01A-46A0-AF3D-93291457CA5FQ35148539-471F22B1-258D-472F-92DF-E7542A2B1872Q35214693-338B2788-2023-467B-A464-1B3281FA8A94Q35356642-33F86822-10EA-4B46-8DBF-E910D72948C6Q36331261-8EC6210A-DF67-4B1C-89E0-D05B43B232EDQ36362594-312C85D4-5DA2-488F-9B20-B7C765FAAEE2Q36471241-96687DED-3ACF-4F02-A8B0-AE2140C34D98Q36607005-F10A4110-169B-4107-91D6-AFBA2FACD5ADQ36950893-562C5EB3-2AE4-4C25-AA92-FC3B6D6CB7B8Q36963945-F0A1F712-932D-4A34-A59E-B73EB25906E3Q37005714-76B5608C-FD9C-4DBA-9F05-70CF7927C960Q37151471-D8908C86-D59C-4C5E-A960-7981DB2E435DQ37586041-6D7909CD-06C9-4838-998E-7129E04D64E4Q37591506-5CA39CCB-6AFF-4AF5-85F4-F731A25C9332Q37683571-00B8BA6E-0888-4101-8746-395A21E512F1Q37706879-3B8C98BF-3ACE-45D2-B282-5215C89F8147Q37728199-48C64F85-B07B-4AB2-882C-42707F6E234BQ37969700-2B365C0C-4D38-42C1-9DD1-50C97EEF9549Q37986822-D1A328A6-CF53-4F58-8C3B-996B9AC9876CQ38200653-B11EEC9D-F561-453F-97C2-B51B170F02A7Q38688788-5B0A155D-2DF3-4F92-B231-046F483A3525Q38731700-D710DA61-0242-4B5C-8D97-30216FCA8CF9Q39196185-1B65A614-24A8-4B92-B1D4-BC2576A5ABD9Q39289164-C0708462-AEC9-44DC-B828-DEE5BD487EA4Q40003002-568DF0FD-C5D1-42A2-8F31-6C0AFDE94AA3Q41396310-DABF984D-E9E0-42AF-B41E-3935320C809BQ42124029-C276C2E3-D9BF-4732-9A19-023F98B6EC46Q42185516-D8F25655-C703-4B97-A0D7-927003A0A3CAQ43677119-A95E41BF-29E0-4C0A-AEA0-506246119B09
P2860
Glycomic and glycoproteomic analysis of serum from patients with stomach cancer reveals potential markers arising from host defense response mechanisms.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Glycomic and glycoproteomic an ...... t defense response mechanisms.
@en
Glycomic and glycoproteomic an ...... t defense response mechanisms.
@nl
type
label
Glycomic and glycoproteomic an ...... t defense response mechanisms.
@en
Glycomic and glycoproteomic an ...... t defense response mechanisms.
@nl
prefLabel
Glycomic and glycoproteomic an ...... t defense response mechanisms.
@en
Glycomic and glycoproteomic an ...... t defense response mechanisms.
@nl
P2093
P356
P1476
Glycomic and glycoproteomic an ...... t defense response mechanisms.
@en
P2093
Anca Nastase
Caitriona Scaife
Ciara McManus
Herve Boissin
Jennifer C Byrne
Jonathan Bones
Niaobh O'Donoghue
Pauline M Rudd
P304
P356
10.1021/PR101036B
P577
2011-01-19T00:00:00Z